Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.43 |
| ▸ | ESRRG | P62508 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL663577 | 0.87 | ALDH1A1 (0.51) | TDP1ALDH1A1LMNASLC6A2SLC6A3 | |
| SCHEMBL20841682 | 0.86 | ALDH1A1 (0.50) | TDP1ALDH1A1LMNASLC6A2SLC6A3 | |
| SCHEMBL16127475 | 0.85 | ALDH1A1 (0.63) | TDP1ALDH1A1LMNASLC6A2SLC6A3 | |
| SCHEMBL23155481 | 0.82 | PTPN1 (0.47) | TDP1ALDH1A1LMNASLC6A2SLC6A3 | |
| SCHEMBL1548979 | 0.82 | ALDH1A1 (0.67) | TDP1ALDH1A1LMNASLC6A2SLC6A3 | |
| SCHEMBL5191638 | 0.81 | TDP1 (0.45) | TDP1ALDH1A1SLC6A2SLC6A3KMT2A | |
| SCHEMBL6832741 | 0.81 | TDP1 (0.59) | TDP1ALDH1A1LMNASLC6A2SLC6A3 | |
| SCHEMBL30141159 | 0.81 | RXRA (0.51) | TDP1ALDH1A1SLC6A2SLC6A3KMT2A | |
| SCHEMBL24983701 | 0.81 | RXRA (0.51) | TDP1ALDH1A1SLC6A2SLC6A3KMT2A | |
| SCHEMBL4758455 | 0.80 | TDP1 (0.73) | TDP1ALDH1A1LMNASLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119758648-A | Nonlinear perfect vector beam generating element, preparation method and application | 南京大学 | 2025-04-04 | — | — | CN | disclosed |
| EP-2423182-A1 | DIACYLETHYLENEDIAMINE COMPOUND | Astellas Pharma Inc. (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120046292-A1 | DIACYLETHYLENEDIAMINE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046292-A1 | DIACYLETHYLENEDIAMINE COMPOUND | DGAT1, DGAT2, DIMT1 | TDP1 2744/4885ALDH1A1 963/4885LMNA 2889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.